Toll-like receptor 3 and interleukin 1β expression in CD34+ cells from patients with rheumatoid arthritis: association with inflammation and vascular involvement

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):922-9. Epub 2014 Nov 7.

Abstract

Objectives: Circulating proangiogenic haematopoietic cells (PHCs), including CD34+ cells, play an important role in endothelial homeostasis. Among PHCs, CD34+ cells are the largest cell population, thus, much of the regenerative/reparative potential of PHCs may be attributed to CD34+ cells. Our aim was to determine the association between inflammation and CD34+ cell number, intracellular levels of reactive oxygen species (ROS) and expression of Toll-like receptor 3 (TLR3) and interleukin 1β (IL-1β), arterial stiffness (AS) indices, and carotid intima-media thickness (cIMT) in patients affected by rheumatoid arthritis (RA).

Methods: CD34+ cells were isolated from 24 RA patients and 26 matched controls. ROS levels, TLR3 and IL-1β expression were measured. C-reactive protein (CRP), fibrinogen, AS, and cIMT were also evaluated.

Results: CD34+ count was lower in RA patients as compared to controls. In CD34+ cells from RA patients, ROS, TLR3 and IL-1β expressions were increased compared to controls. In RA patients, we found higher CRP and fibrinogen levels, and higher values of Pulse Wave Velocity (PWV) and Augmentation Index (AIx), both AS indices, and of cIMT. CD34+ cell numbers were inversely correlated with CRP, TLR3, IL-1β, ROS, and AS indices. TLR3 levels were related to CRP, IL-1β, fibrinogen and ROS. IL-1β levels were correlated with expression of CRP, ROS, and PWV.

Conclusions: Inflammatory status in RA is associated with an increased expression of TLR3 and of IL-1β in CD34+ cells, which appear to affect cell number. These new findings suggest a perspective on accelerated atherosclerosis and vascular damage in RA.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Antigens, CD34 / metabolism*
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / metabolism*
  • Atherosclerosis / blood
  • Atherosclerosis / diagnosis
  • Atherosclerosis / immunology
  • Atherosclerosis / metabolism*
  • Biomarkers / metabolism
  • C-Reactive Protein / metabolism
  • Carotid Intima-Media Thickness
  • Case-Control Studies
  • Cross-Sectional Studies
  • Endothelial Cells / immunology
  • Endothelial Cells / metabolism*
  • Female
  • Hematopoietic Stem Cells / immunology
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Inflammation / blood
  • Inflammation / diagnosis
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation Mediators / metabolism*
  • Interleukin-1beta / metabolism*
  • Male
  • Middle Aged
  • Reactive Oxygen Species / metabolism
  • Risk Factors
  • Toll-Like Receptor 3 / metabolism*
  • Up-Regulation
  • Vascular Stiffness

Substances

  • Antigens, CD34
  • Biomarkers
  • IL1B protein, human
  • Inflammation Mediators
  • Interleukin-1beta
  • Reactive Oxygen Species
  • TLR3 protein, human
  • Toll-Like Receptor 3
  • C-Reactive Protein